EANS-Total Voting Rights: SYGNIS Pharma AG
Release according to article 26a WpHG (Securities Trading Act) with the aim of a Europe-wide distribution

  Total number of voting rights announcement transmitted by euro adhoc. The
  issuer is responsible for the content of this announcement.
SYGNIS Pharma AG hereby announces that at the end of the month December 2012 the
number of voting rights amounts to a total of 9.349.724 voting rights.
The change of total voting rights is effective as of 04.12.2012.

end of announcement                               euro adhoc 

issuer:      SYGNIS Pharma AG
             Im Neuenheimer Feld 515
             D-69120 Heidelberg
phone:       +49 (0)6221 454-6
FAX:         +49 (0)6221 454-777
mail:     contact@sygnis.de
WWW:      http://www.sygnis.de
sector:      Biotechnology
ISIN:        DE000A1RFM03
indexes:     CDAX, Prime All Share
stockmarkets: free trade: Hannover, Berlin, München, Hamburg, Düsseldorf,
             Stuttgart, regulated dealing/prime standard: Frankfurt 
language:   English



Das könnte Sie auch interessieren: